Cargando…
A case report on the efficacy of vigabatrin analogue (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115) in a patient with infantile spasms
West Syndrome is characterized by infantile spasms, a hypsarrhythmic electroencephalogram (EEG) pattern, and a poor neurodevelopmental prognosis. First-line treatments include adrenocorticotrophic hormone (ACTH) and vigabatrin, but adverse effects often limit their use. CPP-115 is a high-affinity vi...
Autores principales: | Doumlele, Kyra, Conway, Erin, Hedlund, Julie, Tolete, Patricia, Devinsky, Orrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024311/ https://www.ncbi.nlm.nih.gov/pubmed/27668180 http://dx.doi.org/10.1016/j.ebcr.2016.08.002 |
Ejemplares similares
-
Mechanism
of Inactivation of γ-Aminobutyric
Acid Aminotransferase by (1S,3S)-3-Amino-4-difluoromethylene-1-cyclopentanoic
Acid (CPP-115)
por: Lee, Hyunbeom, et al.
Publicado: (2015) -
Safety and Efficacy of Vigabatrin for the Treatment of Infantile Spasms
por: Faulkner, Michele A., et al.
Publicado: (2011) -
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
por: Lerner, Jason T, et al.
Publicado: (2010) -
Response to sequential treatment with prednisolone and vigabatrin in infantile spasms
por: Dzau, Winston, et al.
Publicado: (2022) -
Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study
por: Westall, Carol A., et al.
Publicado: (2014)